| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial
|
Rizvi, Naiyer A
|
|
2015
|
16 |
3 |
p. 257-265
9 p.
|
artikel
|
| 2 |
Adjuvant chemotherapy in locally advanced bladder cancer
|
Lu, Kevin
|
|
2015
|
16 |
3 |
p. e103-e104
nvt p.
|
artikel
|
| 3 |
Androgen deprivation with radiotherapy: how long is long enough?
|
Gray, Phillip J
|
|
2015
|
16 |
3 |
p. 244-246
3 p.
|
artikel
|
| 4 |
A stoic irreducibility: I Am Not The Cancer
|
Pitt-Rashid, Josef James
|
|
2015
|
16 |
3 |
p. 255-256
2 p.
|
artikel
|
| 5 |
Bevacizumab and quality of life in advanced cervical cancer
|
Cella, David
|
|
2015
|
16 |
3 |
p. 241-243
3 p.
|
artikel
|
| 6 |
Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology–Gynecologic Oncology Group protocol 240)
|
Penson, Richard T
|
|
2015
|
16 |
3 |
p. 301-311
11 p.
|
artikel
|
| 7 |
Body-mass index, cancer, and implications for screening
|
Eveno, Clarisse
|
|
2015
|
16 |
3 |
p. e102-e103
nvt p.
|
artikel
|
| 8 |
Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial
|
Kunkler, Ian H
|
|
2015
|
16 |
3 |
p. 266-273
8 p.
|
artikel
|
| 9 |
Canada removes ban on physician-assisted suicide
|
Burki, Talha Khan
|
|
2015
|
16 |
3 |
p. e110-
1 p.
|
artikel
|
| 10 |
Can older women with early breast cancer avoid radiation?
|
Hughes, Kevin S
|
|
2015
|
16 |
3 |
p. 235-237
3 p.
|
artikel
|
| 11 |
Correction to Lancet Oncol 2015; 16: 266
|
|
|
2015
|
16 |
3 |
p. e105-
1 p.
|
artikel
|
| 12 |
Correction to Lancet Oncol 2015; 16: 274
|
|
|
2015
|
16 |
3 |
p. e105-
1 p.
|
artikel
|
| 13 |
Correction to Lancet Oncol 2015; 16: 237
|
|
|
2015
|
16 |
3 |
p. e105-
1 p.
|
artikel
|
| 14 |
Correction to Lancet Oncol 2015; 16: 181, 184
|
|
|
2015
|
16 |
3 |
p. e105-
1 p.
|
artikel
|
| 15 |
Correction to Lancet Oncol 2015; 16: 133
|
|
|
2015
|
16 |
3 |
p. e105-
1 p.
|
artikel
|
| 16 |
Cruel imitation
|
Ranscombe, Peter
|
|
2015
|
16 |
3 |
p. 253-254
2 p.
|
artikel
|
| 17 |
Gene mutation order affects cancer behaviour
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
3 |
p. e112-
1 p.
|
artikel
|
| 18 |
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial
|
Zapatero, Almudena
|
|
2015
|
16 |
3 |
p. 320-327
8 p.
|
artikel
|
| 19 |
Hormone therapy increases ovarian cancer risk
|
Tanday, Sanjay
|
|
2015
|
16 |
3 |
p. e112-
1 p.
|
artikel
|
| 20 |
HPV vaccination unlikely to promote risky sexual behaviours
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
3 |
p. e111-
1 p.
|
artikel
|
| 21 |
Hypofractionated radiotherapy in prostate cancer
|
Dearnaley, David P
|
|
2015
|
16 |
3 |
p. 237-238
2 p.
|
artikel
|
| 22 |
Hypofractionated versus conventionally fractionated radiotherapy for patients with prostate cancer (HYPRO): acute toxicity results from a randomised non-inferiority phase 3 trial
|
Aluwini, Shafak
|
|
2015
|
16 |
3 |
p. 274-283
10 p.
|
artikel
|
| 23 |
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial
|
Cesne, Axel Le
|
|
2015
|
16 |
3 |
p. 312-319
8 p.
|
artikel
|
| 24 |
Japanese regulatory authority's perspective on biosimilars
|
Nagai, Sumimasa
|
|
2015
|
16 |
3 |
p. e101-
1 p.
|
artikel
|
| 25 |
Japanese regulatory authority's perspective on biosimilars – Authors' reply
|
Bennett, Charles L
|
|
2015
|
16 |
3 |
p. e102-
1 p.
|
artikel
|
| 26 |
Japanese universal health care faces a crisis in cancer treatment
|
Fujiwara, Yasuhiro
|
|
2015
|
16 |
3 |
p. 251-252
2 p.
|
artikel
|
| 27 |
Large degree of mutation in paediatric brain tumours
|
Burki, Talha Khan
|
|
2015
|
16 |
3 |
p. e111-
1 p.
|
artikel
|
| 28 |
Lenvatinib improves survival in refractory thyroid cancer
|
Mayor, Susan
|
|
2015
|
16 |
3 |
p. e110-
1 p.
|
artikel
|
| 29 |
Less surgery improves survival for advanced colorectal cancer
|
Tanday, Sanjay
|
|
2015
|
16 |
3 |
p. e106-
1 p.
|
artikel
|
| 30 |
Lifetime risk of cancer is more than 50% in Britain
|
Tanday, Sanjay
|
|
2015
|
16 |
3 |
p. e109-
1 p.
|
artikel
|
| 31 |
Minimally invasive test for Barrett's oesophagus
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
3 |
p. e109-
1 p.
|
artikel
|
| 32 |
Morphogenetic fields of embryonic development in locoregional cancer spread
|
Höckel, Michael
|
|
2015
|
16 |
3 |
p. e148-e151
nvt p.
|
artikel
|
| 33 |
Moving the goal posts in prostate cancer trials
|
Madan, Ravi A
|
|
2015
|
16 |
3 |
p. 247-249
3 p.
|
artikel
|
| 34 |
Necitumumab for patients with non-squamous NSCLC: uninspiring results
|
Zhou, Fei
|
|
2015
|
16 |
3 |
p. 246-247
2 p.
|
artikel
|
| 35 |
Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study
|
Paz-Ares, Luis
|
|
2015
|
16 |
3 |
p. 328-337
10 p.
|
artikel
|
| 36 |
Nivolumab for advanced squamous cell lung cancer: what are the next steps?
|
de Mello, Ramon Andrade
|
|
2015
|
16 |
3 |
p. 234-235
2 p.
|
artikel
|
| 37 |
Nivolumab shows clinical activity in Hodgkin's lymphoma
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
3 |
p. e108-
1 p.
|
artikel
|
| 38 |
Optimisation of the continuum of supportive and palliative care for patients with breast cancer in low-income and middle-income countries: executive summary of the Breast Health Global Initiative, 2014
|
Distelhorst, Sandra R
|
|
2015
|
16 |
3 |
p. e137-e147
nvt p.
|
artikel
|
| 39 |
Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomised, placebo-controlled trial
|
Saad, Fred
|
|
2015
|
16 |
3 |
p. 338-348
11 p.
|
artikel
|
| 40 |
PET-adapted salvage therapy in Hodgkin's lymphoma
|
Tirelli, Umberto
|
|
2015
|
16 |
3 |
p. 239-240
2 p.
|
artikel
|
| 41 |
PET-adapted sequential salvage therapy with brentuximab vedotin followed by augmented ifosamide, carboplatin, and etoposide for patients with relapsed and refractory Hodgkin's lymphoma: a non-randomised, open-label, single-centre, phase 2 study
|
Moskowitz, Alison J
|
|
2015
|
16 |
3 |
p. 284-292
9 p.
|
artikel
|
| 42 |
Prognostic accuracy in second-line renal cancer therapy
|
Bex, Axel
|
|
2015
|
16 |
3 |
p. 240-241
2 p.
|
artikel
|
| 43 |
Radiation therapy in the locoregional treatment of triple-negative breast cancer
|
Moran, Meena S
|
|
2015
|
16 |
3 |
p. e113-e122
nvt p.
|
artikel
|
| 44 |
Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|
Armenian, Saro H
|
|
2015
|
16 |
3 |
p. e123-e136
nvt p.
|
artikel
|
| 45 |
Rethinking trial eligibility in the NCD era
|
The Lancet Oncology,
|
|
2015
|
16 |
3 |
p. 233-
1 p.
|
artikel
|
| 46 |
Side-effects of cancer drugs are under-reported in trials
|
Mayor, Susan
|
|
2015
|
16 |
3 |
p. e107-
1 p.
|
artikel
|
| 47 |
Stereotactic radiosurgery alone for brain metastases
|
Sahgal, Arjun
|
|
2015
|
16 |
3 |
p. 249-250
2 p.
|
artikel
|
| 48 |
Targeted biopsy boosts detection of high-risk prostate cancer
|
Tanday, Sanjay
|
|
2015
|
16 |
3 |
p. e107-
1 p.
|
artikel
|
| 49 |
The art of living to the last
|
Bagcchi, Sanjeet
|
|
2015
|
16 |
3 |
p. 256-
1 p.
|
artikel
|
| 50 |
The International Metastatic Renal Cell Carcinoma Database Consortium model as a prognostic tool in patients with metastatic renal cell carcinoma previously treated with first-line targeted therapy: a population-based study
|
Ko, Jenny J
|
|
2015
|
16 |
3 |
p. 293-300
8 p.
|
artikel
|
| 51 |
The oncological package: a new source of concern in Poland's health system
|
Holecki, Tomasz
|
|
2015
|
16 |
3 |
p. e104-
1 p.
|
artikel
|
| 52 |
Trabectedin tactics: from sea squirts to sarcomas
|
Randall, R Lor
|
|
2015
|
16 |
3 |
p. 243-244
2 p.
|
artikel
|
| 53 |
UK and US governments to fund personalised medicine
|
Burki, Talha
|
|
2015
|
16 |
3 |
p. e108-
1 p.
|
artikel
|
| 54 |
Unmet needs of cancer survivors
|
Burki, Talha Khan
|
|
2015
|
16 |
3 |
p. e106-
1 p.
|
artikel
|
| 55 |
Wild: a journey through wilderness and memory
|
Cagney, Hannah
|
|
2015
|
16 |
3 |
p. 254-255
2 p.
|
artikel
|
Tijdschrift beschrijving